Colfax Corporation operates as a diversified technology company worldwide. More Details
Fair value with moderate growth potential.
Share Price & News
How has Colfax's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CFX has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: CFX underperformed the US Machinery industry which returned 16% over the past year.
Return vs Market: CFX underperformed the US Market which returned 19.5% over the past year.
Price Volatility Vs. Market
How volatile is Colfax's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall StIs Colfax Corporation (NYSE:CFX) Trading At A 24% Discount?
2 months ago | Simply Wall StHave Insiders Been Selling Colfax Corporation (NYSE:CFX) Shares This Year?
5 months ago | Simply Wall StColfax Corporation’s (NYSE:CFX) Investment Returns Are Lagging Its Industry
Is Colfax undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: CFX ($31.29) is trading below our estimate of fair value ($46.89)
Significantly Below Fair Value: CFX is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: CFX is poor value based on its PE Ratio (110.7x) compared to the US Machinery industry average (25.7x).
PE vs Market: CFX is poor value based on its PE Ratio (110.7x) compared to the US market (19x).
Price to Earnings Growth Ratio
PEG Ratio: CFX is poor value based on its PEG Ratio (2.2x)
Price to Book Ratio
PB vs Industry: CFX is good value based on its PB Ratio (1.1x) compared to the US Machinery industry average (2.4x).
How is Colfax forecast to perform in the next 1 to 3 years based on estimates from 16 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CFX's forecast earnings growth (49.7% per year) is above the savings rate (2.2%).
Earnings vs Market: CFX's earnings (49.7% per year) are forecast to grow faster than the US market (22.1% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: CFX's revenue (6.6% per year) is forecast to grow slower than the US market (10% per year).
High Growth Revenue: CFX's revenue (6.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CFX's Return on Equity is forecast to be low in 3 years time (6.2%).
How has Colfax performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CFX has a large one-off loss of $118.0M impacting its July 3 2020 financial results.
Growing Profit Margin: CFX's current net profit margins (1.2%) are higher than last year (0.7%).
Past Earnings Growth Analysis
Earnings Trend: CFX's earnings have declined by 41% per year over the past 5 years.
Accelerating Growth: CFX's earnings growth over the past year (92%) exceeds its 5-year average (-41% per year).
Earnings vs Industry: CFX earnings growth over the past year (92%) exceeded the Machinery industry -13.1%.
Return on Equity
High ROE: CFX's Return on Equity (1.3%) is considered low.
How is Colfax's financial position?
Financial Position Analysis
Short Term Liabilities: CFX's short term assets ($1.2B) exceed its short term liabilities ($758.7M).
Long Term Liabilities: CFX's short term assets ($1.2B) do not cover its long term liabilities ($3.0B).
Debt to Equity History and Analysis
Debt Level: CFX's debt to equity ratio (66.2%) is considered high.
Reducing Debt: CFX's debt to equity ratio has increased from 41% to 66.2% over the past 5 years.
Debt Coverage: CFX's debt is not well covered by operating cash flow (9.5%).
Interest Coverage: CFX's interest payments on its debt are not well covered by EBIT (2.4x coverage).
What is Colfax current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CFX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CFX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CFX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CFX's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CFX's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Matt Trerotola (53 yo)
Mr. Matthew L. Trerotola, also known as Matt, has been the Chief Executive Officer of Colfax Corporation since July 24, 2015 and has been its President since July 2015. Mr. Trerotola has been the President ...
CEO Compensation Analysis
Compensation vs Market: Matt's total compensation ($USD8.43M) is above average for companies of similar size in the US market ($USD5.61M).
Compensation vs Earnings: Matt's compensation has increased by more than 20% in the past year.
|Co-Founder & Chairman of the Board||no data||US$1.00||7.36% |
|Executive VP of Finance & CFO||4.25yrs||US$4.15m||0.018% |
|Executive Vice President of Strategy & Business Development||7.25yrs||US$2.98m||0.071% |
|Executive VP and CEO & President of ESAB||4.42yrs||US$3.06m||0.048% |
|CEO of DJO & Executive VP||3.92yrs||US$4.44m||0% |
|Interim Senior Vice President of Global Operations & Americas||no data||no data||no data|
|Vice President of Investor Relations||5.83yrs||no data||no data|
|Senior VP||1.67yrs||no data||no data|
|Senior VP & Chief Human Resources Officer||1.75yrs||no data||no data|
|Senior Vice President of Colfax Business System & Supply Chain Strategy||3yrs||no data||0.0021% |
|Head of Treasury||no data||no data||no data|
Experienced Management: CFX's management team is considered experienced (4.3 years average tenure).
|Co-Founder & Chairman of the Board||no data||US$1.00||7.36% |
|Independent Director||4.33yrs||US$213.19k||0.021% |
|Independent Director||12.42yrs||US$228.19k||0.18% |
|Independent Director||10.08yrs||US$233.19k||0.0063% |
|Independent Director||12.42yrs||US$213.19k||0.050% |
|Independent Director||12.42yrs||US$213.19k||0.018% |
|Independent Director||3.08yrs||US$213.19k||0.018% |
|Independent Director||11.67yrs||US$228.19k||0.021% |
|Independent Director||0.75yr||no data||0.0081% |
Experienced Board: CFX's board of directors are seasoned and experienced ( 10.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: CFX insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Colfax Corporation's company bio, employee growth, exchange listings and data sources
- Name: Colfax Corporation
- Ticker: CFX
- Exchange: NYSE
- Founded: 1860
- Industry: Industrial Machinery
- Sector: Capital Goods
- Market Cap: US$3.704b
- Shares outstanding: 118.39m
- Website: https://www.colfaxcorp.com
Number of Employees
- Colfax Corporation
- 420 National Business Parkway
- 5th Floor
- Annapolis Junction
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|CFX||NYSE (New York Stock Exchange)||Yes||Common Stock||US||USD||May 2008|
|C52||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||May 2008|
|0I1B||LSE (London Stock Exchange)||Yes||Common Stock||GB||USD||May 2008|
Colfax Corporation operates as a diversified technology company worldwide. The company operates through two segments, Medical Technology and Fabrication Technology. The Medical Technology segment offers or ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/10/20 00:49|
|End of Day Share Price||2020/10/19 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.